Affimed N.V. (AFMD)
NASDAQ: AFMD · Real-Time Price · USD
0.7000
+0.0063 (0.91%)
May 8, 2025, 4:00 PM EDT - Market closed
Affimed Market Cap
Affimed has a market cap or net worth of $11.47 million as of May 8, 2025. Its market cap has decreased by -84.92% in one year.
Market Cap
11.47M
Enterprise Value
-1.03M
1-Year Change
-84.92%
Ranking
Category
Stock Price
$0.70
Market Cap Chart
Since September 12, 2014, Affimed's market cap has decreased from $126.70M to $11.47M, a decrease of -90.94%. That is a compound annual growth rate of -20.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2025 | 11.40M | -41.54% |
| Dec 31, 2024 | 19.50M | -79.10% |
| Dec 29, 2023 | 93.30M | -49.62% |
| Dec 30, 2022 | 185.20M | -65.86% |
| Dec 31, 2021 | 542.50M | 22.24% |
| Dec 31, 2020 | 443.80M | 159.38% |
| Dec 31, 2019 | 171.10M | 17.59% |
| Dec 31, 2018 | 145.50M | 236.81% |
| Dec 29, 2017 | 43.20M | -27.88% |
| Dec 30, 2016 | 59.90M | -64.93% |
| Dec 31, 2015 | 170.80M | 23.86% |
| Dec 31, 2014 | 137.90M | 8.84% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.45B |
| Johnson & Johnson | 372.94B |
| UnitedHealth Group | 368.47B |
| AbbVie | 346.84B |
| Novo Nordisk | 309.41B |
| Abbott Laboratories | 230.70B |
| AstraZeneca | 221.69B |
| Novartis AG | 221.37B |